Literature DB >> 3364665

[Postoperative on-demand analgesia with buprenorphine].

K A Lehmann1, B Gördes.   

Abstract

Patient-controlled analgesia (PCA) was studied during the early postoperative period. Subjects were 40 ASA I-III patients recovering from elective major and minor surgery. Buprenorphine doses of 40 micrograms each were available whenever the patients felt pain relief necessary, and were delivered by a microprocessor-controlled injection pump (On-Demand Analgesia Computer). The hourly maximum dose was set at 320 micrograms with a lockout time of 1 minute. A continuous low-dose buprenorphine infusion (5 micrograms/h) was additionally administered in order to prevent catheter obstruction. The duration of the PCA period was 16.9 +/- 5.1 h (mean +/- SD). During this time, 16.1 +/- 11.3 demands per patient were recorded resulting in individual buprenorphine consumptions of 0.63 +/- 0.59 micrograms/kg/h. More buprenorphine was needed following abdominal surgery compared with orthopedic patients, although pain relief was found slightly less in the former group. Buprenorphine consumption was significantly higher in female than in male patients. Overall efficacy and patient acceptance proved to be excellent. The effectiveness of PCA was judged superior by about 93% of patients when compared with previously experienced postoperative analgesia. Side-effects (sweating, nausea, emesis) occurred in about 10% of cases but were usually of minor intensity. No circulatory or respiratory problems were observed during the PCA period.

Entities:  

Mesh:

Substances:

Year:  1988        PMID: 3364665

Source DB:  PubMed          Journal:  Anaesthesist        ISSN: 0003-2417            Impact factor:   1.041


  2 in total

1.  Influence of naloxone on the postoperative analgesic and respiratory effects of buprenorphine.

Authors:  K A Lehmann; U Reichling; R Wirtz
Journal:  Eur J Clin Pharmacol       Date:  1988       Impact factor: 2.953

2.  [Transdermal buprenorphine for treatment of chronic tumor and non-tumor pain].

Authors:  Rudolf Likar; Norbert Griessinger; Anton Sadjak; Reinhard Sittl
Journal:  Wien Med Wochenschr       Date:  2003
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.